Literature DB >> 31711922

Use of Treatments for Irritable Bowel Syndrome and Patient Satisfaction Based on the IBS in America Survey.

Vikram Rangan1, Sarah Ballou2, Andrea Shin3, Michael Camilleri4, Anthony Lembo2.   

Abstract

Entities:  

Keywords:  Constipation; Diarrhea; Irritable Bowel Syndrome; Patient Satisfaction; Physician Satisfaction; Treatment Utilization

Mesh：

Substances：

Year:  2019        PMID： 31711922      PMCID： PMC7212496          DOI： 10.1053/j.gastro.2019.10.036

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  8 in total

Review 1.  Prebiotics and Probiotics in Digestive Health.

Authors:  Eamonn M M Quigley
Journal:  Clin Gastroenterol Hepatol       Date:  2018-09-26       Impact factor: 11.382

2.  Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.

Authors:  Rebecca M Lovell; Alexander C Ford
Journal:  Clin Gastroenterol Hepatol       Date:  2012-03-15       Impact factor: 11.382

3.  Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Irritable Bowel Syndrome with Constipation (BURDEN IBS-C) Study: Results of an Online Questionnaire.

Authors:  Eamonn M M Quigley; John Horn; Michele Kissous-Hunt; Robert A Crozier; Lucinda A Harris
Journal:  Adv Ther       Date:  2018-06-26       Impact factor: 3.845

4.  Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.

Authors:  A P S Hungin; L Chang; G R Locke; E H Dennis; V Barghout
Journal:  Aliment Pharmacol Ther       Date:  2005-06-01       Impact factor: 8.171

5.  Comparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome.

Authors:  Gregory S Sayuk; Ray Wolf; Lin Chang
Journal:  Am J Gastroenterol       Date:  2017-01-17       Impact factor: 10.864

6.  Understanding symptom burden and attitudes to irritable bowel syndrome with diarrhoea: Results from patient and healthcare professional surveys.

Authors:  Hans Törnblom; Richard Goosey; Gwen Wiseman; Stephen Baker; Anton Emmanuel
Journal:  United European Gastroenterol J       Date:  2018-07-09       Impact factor: 4.623

7.  A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.

Authors:  Heidi Maria Staudacher; Miranda C E Lomer; Freda M Farquharson; Petra Louis; Francesca Fava; Elena Franciosi; Matthias Scholz; Kieran M Tuohy; James O Lindsay; Peter M Irving; Kevin Whelan
Journal:  Gastroenterology       Date:  2017-06-15       Impact factor: 22.682

Review 8.  The epidemiology of irritable bowel syndrome.

Authors:  Caroline Canavan; Joe West; Timothy Card
Journal:  Clin Epidemiol       Date:  2014-02-04       Impact factor: 4.790
  8 in total
  8 in total

1.  Psychological Predictors of Response to Open-Label Versus Double-Blind Placebo in a Randomized Controlled Trial in Irritable Bowel Syndrome.

Authors:  Sarah Ballou; Julia W Haas; Johanna Iturrino; Judy Nee; Irving Kirsch; Vikram Rangan; Vivian Cheng; Anthony Lembo; Ted J Kaptchuk; John M Kelley
Journal:  Psychosom Med       Date:  2022-04-12       Impact factor: 3.864

2.  Baseline Predictors of Discontinuation of Prescription Drug Therapy for IBS-C: Cohort Analysis at an Integrated Healthcare System.

Authors:  Eric D Shah; Darren M Brenner; Vincent L Chen
Journal:  Dig Dis Sci       Date:  2021-03-29       Impact factor: 3.199

Review 3.  Diarrhea-Predominant and Constipation-Predominant Irritable Bowel Syndrome: Current Prescription Drug Treatment Options.

Authors:  Emily V Wechsler; Eric D Shah
Journal:  Drugs       Date:  2021-11-02       Impact factor: 9.546

4.  Epidemiology, Clinical Features, and Prescribing Patterns of Irritable Bowel Syndrome in Taiwan.

Authors:  Yu-Tung Lai; Chung-Yu Chen; Ming-Jong Bair
Journal:  Front Pharmacol       Date:  2021-12-09       Impact factor: 5.810

5.  Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D.

Authors:  Prashant Singh; Eric J Alm; John M Kelley; Vivian Cheng; Mark Smith; Zain Kassam; Judy Nee; Johanna Iturrino; Anthony Lembo
Journal:  Gut Microbes       Date:  2022 Jan-Dec

6.  Effect of Shugan Jianpi Recipe Combined with Cross Moxibustion on Biochemical Examination Indexes and Total Score of TCM Symptoms in Patients with Spleen-Stomach Damp-Heat Diarrhea Irritable Bowel Syndrome.

Authors:  Di Liu; Meiying Ruan; Chenghui Tong; Rongrong Huang
Journal:  Comput Math Methods Med       Date:  2022-04-23       Impact factor: 2.809

7.  Satisfaction With Telehealth Among Patients With Irritable Bowel Syndrome During COVID-19: Cross-Sectional Survey Findings.

Authors:  Christine Yu; Stephanie Tovar; Jiaxiao Shi; Ariadna Padilla; Dana Pounds; Welmoed K van Deen; Christopher V Almario; Bechien U Wu
Journal:  Clin Transl Gastroenterol       Date:  2022-09-01       Impact factor: 4.396

Review 8.  Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials.

Authors:  Eric D Shah; Brian E Lacy; William D Chey; Lin Chang; Darren M Brenner
Journal:  Am J Gastroenterol       Date:  2021-08-01       Impact factor: 12.045
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.